| P/E (FY) | — | Sales (TTM) | $746.0M |
| Earnings (TTM) | -$99.2M | ROE | −12.42% |
| Net Margin | −14.85% | ROIC | −8.74% |
| Debt / Equity | 0.41 | TD / EBITDA | — |
| EPS Growth 3Y | — | Sales Growth 3Y | 12.58% |
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and United Kingdom, serving hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. Its services include cytogenetics, fluorescence in-situ hybridization, flow cytometry, and immunohistochemistry and digital imaging testing for detecting and analyzing cellular and chromosomal characteristics related to disease.
| Market Cap | $1.99B | Trading Days | 5293 |
| 52W High | 16.10 |
| 52W Low | 4.72 |
| % Off High | −5.16% |
| YTD | 29.85% | 1Y | 190.86% |
| 3Y | −11.89% | 5Y | −66.59% |
| 10Y | 76.47% | Since incept. (ann.) | 19.69% |
Reportable 100%
| Ann. Volatility (1Y) | 62.91% | Ann. Volatility (3Y) | 63.56% |
| Sharpe (1Y) | 1.69 | Sharpe (3Y) | 0.26 |
| Max Drawdown (1Y) | −45.61% | Max Drawdown (3Y) | −76.65% |
| Beta (3Y, vs SPY) | 2.23 |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| ULS | UL Solutions Inc. | $18.75B | 57.7 |
| BNBX | BNB PLUS CORP. | $647,751 | — |
| OUST | Ouster, Inc. | $1.99B | — |
| CCS | Century Communities, Inc. | $1.98B | 14.3 |
| LPG | DORIAN LPG LTD. | $1.96B | 10.1 |
| LIND | LINDBLAD EXPEDITIONS HOLDINGS, INC. | $1.95B | — |
| YSS | York Space Systems Inc. | $1.95B | — |
| NSP | INSPERITY, INC. | $2.03B | — |
| ASTH | Astrana Health, Inc. | $2.03B | 79.4 |
| ALG | ALAMO GROUP INC | $1.91B | 18.3 |
| GRC | GORMAN RUPP CO | $2.07B | 38.8 |
| CADLR.OL | CADELER A/S | $1.91B |
| — |